ImmunityBio (IBRX) AI Analysis
IBRX$6.22+0.24 +4.10%
Market cap$6.62BEnterprise value$10.20BRevenue (TTM)$165.79MMarket position—
Score
65
Bullish
Value
63
Quality
33
Growth
100
AI Score 30. ImmunityBio, Inc. has a high market cap of approximately $9.46 billion but is facing significant financial challenges, with a net profit margin of -5.99% and a price-to-sales ratio of 57.1, indicating overvaluation relative to its revenue